Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 7/2017

01-07-2017 | Review

Rescue of recombinant Newcastle disease virus: a short history of how it all started

Authors: Aidin Molouki, Ben Peeters

Published in: Archives of Virology | Issue 7/2017

Login to get access

Abstract

Reverse genetics of viruses has come a long way, and many recombinant viruses have been generated since the first successful “rescues” were reported in the late 1970s. Recombinant Newcastle disease virus (rNDV), a non-segmented negative-sense RNA virus (NSNSV), was first rescued in 1999 using a reverse genetics approach similar to that reported for other recombinant viruses of the order Mononegavirales a few years before. The route from an original NDV isolate to the generation of its recombinant counterpart requires many steps that have to be sequentially and carefully completed. Background knowledge of each of these steps is essential because it allows one to make the best choices for fulfilling the specific requirements of the final recombinant virus. We have previously reviewed the latest strategies in cloning the NDV full-length cDNA into transcription vectors and the use of different RNA polymerase systems for the generation of viral RNA from plasmid DNA. In this article, we review a number of discoveries on the mechanism of transcription and replication of NDV, including a brief history behind the discovery of its RNP complex. This includes the generation of artificial and functional RNP constructs, in combination with the smart use of available knowledge and technologies that ultimately resulted in rescue of the first rNDV.
Literature
1.
Ball LA (1992) Cellular expression of a functional nodavirus RNA replicon from vaccinia virus vectors. J Virol 66:2335–2345PubMedPubMedCentral
2.
Baltimore D, Huang AS, Stampfer M (1970) Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci USA 66:572–576PubMedPubMedCentralCrossRef
3.
4.
5.
Boursnell ME, Green PF, Campbell JI, Deuter A, Peters RW, Tomley FM, Samson AC, Chambers P, Emmerson PT, Binns MM (1990) Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. J Gen Virol 71:621–628PubMedCrossRef
6.
Boursnell ME, Green PF, Samson AC, Campbell JI, Deuter A, Peters RW, Millar NS, Emmerson PT, Binns MM (1990) A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 178:297–300PubMedCrossRef
7.
Bratt MA, Robinson WS (1967) Ribonucleic acid synthesis in cells infected with Newcastle disease virus. J Mol Biol 23:1–21CrossRef
8.
Bridgen A, Elliott RM (1996) Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci USA 93:15400–15404PubMedPubMedCentralCrossRef
9.
Bridgen A (2013) Introduction. In: Bridgen A (ed) Reverse genetics of RNA viruses : applications and perspectives. Wiley-Blackwell, Chichester, pp 1–15
10.
Britton P, Green P, Kottier S, Mawditt KL, Penzes Z, Cavanagh D, Skinner MA (1996) Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus. J Gen Virol 77:963–967PubMedCrossRef
11.
Brown F (1987) The family of rhabdoviridae: general description and taxonomy. In: Wagner RR (ed) The rhabdoviruses. Plenum, New York, p xviii
12.
Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251–259PubMedPubMedCentral
13.
Calain P, Curran J, Kolakofsky D, Roux L (1992) Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology 191:62–71PubMedCrossRef
14.
Calain P, Roux L (1993) The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 67:4822–4830PubMedPubMedCentral
15.
Cassel WA, Garrett RE (1965) Newcastle disease virus as an antineoplastic agent. Cancer 18:863–868PubMedCrossRef
16.
Cech TR, Zaug AJ, Grabowski PJ (1981) In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27:487–496PubMedCrossRef
17.
Chambers P, Millar NS, Bingham RW, Emmerson PT (1986) Molecular cloning of complementary DNA to Newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein. J Gen Virol 67:475–486PubMedCrossRef
18.
Cho S-H, Kwon H-J, Kim T-E, Kim J-H, Yoo H-S, Park M-H, Park Y-H, Kim S-J (2008) Characterization of a recombinant newcastle disease virus vaccine strain. Clin Vaccine Immunol 15:1572–1579PubMedPubMedCentralCrossRef
19.
Choppin P, Compans R (1975) Reproduction of Paramyxoviruses. In: Fraenkel-Conrat H, Wagner R (eds) Comprehensive virology. Springer, US, pp 95–178CrossRef
20.
Collins PL, Mink MA, Stec DS (1991) Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. Proc Natl Acad Sci USA 88:9663–9667PubMedPubMedCentralCrossRef
21.
Collins PL, Mink MA, Hill Iii MG, Camargo E, Grosfeld H, Stec DS (1993) Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA. Virology 195:252–256PubMedCrossRef
22.
Conzelmann KK, Schnell M (1994) Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins. J Virol 68:713–719PubMedPubMedCentral
23.
Conzelmann KK (1998) Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes. Annu Rev Genet 32:123–162PubMedCrossRef
24.
Conzelmann KK (2004) Reverse genetics of mononegavirales. Curr Top Microbiol Immunol 283:1–41PubMed
25.
26.
Curran J, Boeck R, Kolakofsky D (1991) The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J 10:3079–3085PubMedPubMedCentral
27.
Czegledi A, Ujvari D, Somogyi E, Wehmann E, Werner O, Lomniczi B (2006) Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res 120:36–48PubMedCrossRef
28.
de Leeuw O, Peeters B (1999) Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol 80:131–136PubMedCrossRef
29.
30.
Dortmans JC, Peeters BP, Koch G (2012) Newcastle disease virus outbreaks: vaccine mismatch or inadequate application? Vet Microbiol 160:17–22PubMedCrossRef
31.
Durbin AP, Siew JW, Murphy BR, Collins PL (1997) Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology 234:74–83PubMedCrossRef
32.
Egelman EH, Wu SS, Amrein M, Portner A, Murti G (1989) The Sendai virus nucleocapsid exists in at least four different helical states. J Virol 63:2233–2243PubMedPubMedCentral
33.
Elroy-Stein O, Moss B (1990) Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc Natl Acad Sci USA 87:6743–6747PubMedPubMedCentralCrossRef
34.
Emerson SU, Wagner RR (1972) Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J Virol 10:297–309PubMedPubMedCentral
35.
Emerson SU, Wagner RR (1973) L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. J Virol 12:1325–1335PubMedPubMedCentral
36.
Emerson SU, Yu Y (1975) Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus. J Virol 15:1348–1356PubMedPubMedCentral
37.
Emerson SU (1987) Transcription of vesicular stomatitis virus. In: Wagner RR (ed) The rhabdoviruses. Plenum, New York; London, pp 245–269CrossRef
38.
Enami M, Luytjes W, Krystal M, Palese P (1990) Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci USA 87:3802–3805PubMedPubMedCentralCrossRef
39.
Espion D, de Henau S, Letellier C, Wemers CD, Brasseur R, Young JF, Gross M, Rosenberg M, Meulemans G, Burny A (1987) Expression at the cell surface of native fusion protein of the Newcastle disease virus (NDV) strain Italien from cloned cDNA. Arch Virol 95:79–95PubMedCrossRef
40.
Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73:9679–9682PubMedPubMedCentral
41.
Fuerst TR, Niles EG, Studier FW, Moss B (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122–8126PubMedPubMedCentralCrossRef
42.
Goff SP, Berg P (1976) Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells. Cell 9:695–705PubMedCrossRef
43.
44.
Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35:849–857PubMedCrossRef
45.
Hu H, Roth JP, Estevez CN, Zsak L, Liu B, Yu Q (2011) Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. Vaccine 29:8624–8633PubMedCrossRef
46.
Hu S, Ma H, Wu Y, Liu W, Wang X, Liu Y, Liu X (2009) A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27:904–910PubMedCrossRef
47.
Huang AS, Baltimore D, Stampfer M (1970) Ribonucleic acid synthesis of vesicular stomatitis virus: III. Multiple complementary messenger RNA molecules. Virology 42:946–957PubMedCrossRef
48.
Huang AS, Baltimore D, Bratt MA (1971) Ribonucleic acid polymerase in virions of Newcastle disease virus: comparison with the vesicular stomatitis virus polymerase. J Virol 7:389–394PubMedPubMedCentral
49.
Huang Z, Elankumaran S, Panda A, Samal SK (2003) Recombinant Newcastle disease virus as a vaccine vector. Poult Sci 82:899–906PubMedCrossRef
50.
Iverson LE, Rose JK (1981) Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell 23:477–484PubMedCrossRef
51.
Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, Nagai Y (1996) Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569–579PubMedCrossRef
52.
Kim SH, Samal SK (2016) Newcastle disease virus as a vaccine vector for development of human and veterinary vaccines. Viruses 8
53.
Kingsbury DW (1966) Newcastle disease virus RNA: II. Preferential synthesis of RNA complementary to parental viral RNA by chick embryo cells. J Mol Biol 18:204–214PubMedCrossRef
54.
Kolakofsky D, Pelet T, Garcin D, Sp Hausmann, Curran J, Roux L (1998) Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 72:891–899PubMedPubMedCentral
55.
Kolakofsky D, Roux L, Garcin D, Ruigrok RW (2005) Paramyxovirus mRNA editing, the “rule of six” and error catastrophe: a hypothesis. J Gen Virol 86:1869–1877PubMedCrossRef
56.
Krishnamurthy S, Huang Z, Samal SK (2000) Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278:168–182PubMedCrossRef
57.
Kruger K, Grabowski PJ, Zaug AJ, Sands J, Gottschling DE, Cech TR (1982) Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31:147–157PubMedCrossRef
58.
Kuo MY, Sharmeen L, Dinter-Gottlieb G, Taylor J (1988) Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol 62:4439–4444PubMedPubMedCentral
59.
Lamb RA, Kolakofsky D (2001) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields Virology. Lippincott Williams & Wilkins, Philadelphia, pp 1305–1340
60.
61.
Luytjes W, Krystal M, Enami M, Parvin JD, Palese P (1989) Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59:1107–1113PubMedCrossRef
62.
Molouki A, Peeters B (2016) Rescue of recombinant Newcastle disease virus: current cloning strategies and RNA polymerase provision systems. Arch Virol 162(1):1–12PubMedCrossRef
63.
Murphy SK, Parks GD (1997) Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Virology 232:145–157PubMedCrossRef
64.
Murulitharan K, Yusoff K, Omar AR, Molouki A (2013) Characterization of Malaysian velogenic NDV strain AF2240-I genomic sequence: a comparative study. Virus Genes 46:431–440PubMedCrossRef
65.
Nagai Y (2013) Sendai virus vector : advantages and applications. Springer, JapanCrossRef
66.
Naito S, Ishihama A (1976) Function and structure of RNA polymerase from vesicular stomatitis virus. J Biol Chem 251:4307–4314PubMed
67.
Neumann G, Zobel A, Hobom G (1994) RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology 202:477–479PubMedCrossRef
68.
Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96:9345–9350PubMedPubMedCentralCrossRef
69.
Neumann G, Whitt MA, Kawaoka Y (2002) A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? J Gen Virol 83:2635–2662PubMedCrossRef
70.
Neumann G, Kawaoka Y (2004) Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. Curr Top Microbiol Immunol 283:43–60PubMed
71.
Pal R, Grinnell BW, Snyder RM, Wagner RR (1985) Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J Virol 56:386–394PubMedPubMedCentral
72.
Palese P, Zheng H, Engelhardt OG, Pleschka S, Garcia-Sastre A (1996) Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci USA 93:11354–11358PubMedPubMedCentralCrossRef
73.
74.
75.
Pattnaik AK, Wertz GW (1990) Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs. J Virol 64:2948–2957PubMedPubMedCentral
76.
Pattnaik AK, Wertz GW (1991) Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles. Proc Natl Acad Sci USA 88:1379–1383PubMedPubMedCentralCrossRef
77.
Pattnaik AK, Ball LA, LeGrone AW, Wertz GW (1992) Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell 69:1011–1020PubMedCrossRef
78.
Pattnaik AK, Ball LA, LeGrone A, Wertz GW (1995) The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles. Virology 206:760–764PubMedCrossRef
79.
Peeters BP, de Leeuw OS, Koch G, Gielkens AL (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73:5001–5009PubMedPubMedCentral
80.
Peeters BP, Gruijthuijsen YK, de Leeuw OS, Gielkens AL (2000) Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol 145:1829–1845PubMedCrossRef
81.
Peeters BP, de Leeuw OS, Verstegen I, Koch G, Gielkens AL (2001) Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine 19:1616–1627PubMedCrossRef
82.
Perlman SM, Huang AS (1973) RNA synthesis of vesicular stomatitis virus V. Interactions between transcription and replication. J Virol 12:1395–1400PubMedPubMedCentral
83.
Perrotta AT, Been MD (1991) A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature 350:434–436PubMedCrossRef
84.
Pinney DF, Emerson SU (1982) In vitro synthesis of triphosphate-initiated N-gene mRNA oligonucleotides is regulated by the matrix protein of vesicular stomatitis virus. J Virol 42:897–904PubMedPubMedCentral
85.
Racaniello VR, Baltimore D (1981) Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214:916–919PubMedCrossRef
86.
Romer-Oberdorfer A, Mundt E, Mebatsion T, Buchholz UJ, Mettenleiter TC (1999) Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80(Pt 11):2987–2995PubMedCrossRef
87.
Rothenberg E, Smotkin D, Baltimore D, Weinberg RA (1977) In vitro synthesis of infectious DNA of murine leukaemia virus. Nature 269:122–126PubMedCrossRef
88.
Samal SK, Collins PL (1996) RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. J Virol 70:5075–5082PubMedPubMedCentral
89.
Samal SK (2011) The biology of paramyxoviruses. Caister Academic Press, Norfolk
90.
Schirrmacher V, Fournier P (2009) Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer. Methods Mol Biol 542:565–605PubMedCrossRef
91.
92.
Seong BL, Brownlee GG (1992) A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo. Virology 186:247–260PubMedCrossRef
93.
Sharmeen L, Kuo MY, Dinter-Gottlieb G, Taylor J (1988) Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol 62:2674–2679PubMedPubMedCentral
94.
Sidhu MS, Chan J, Kaelin K, Spielhofer P, Radecke F, Schneider H, Masurekar M, Dowling PC, Billeter MA, Udem SA (1995) Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology 208:800–807PubMedCrossRef
95.
96.
Sutter G, Ohlmann M, Erfle V (1995) Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 371:9–12PubMedCrossRef
97.
Szilágyi JF, Uryvayev L (1973) Isolation of an infectious ribonucleoprotein from Vesicular Stomatitis virus containing an active RNA transcriptase. J Virol 11:279–286PubMedPubMedCentral
98.
Taniguchi T, Palmieri M, Weissmann C (1978) QB DNA-containing hybrid plasmids giving rise to QB phage formation in the bacterial host. Nature 274:223–228PubMedCrossRef
99.
Taylor J, Edbauer C, Rey-Senelonge A, Bouquet JF, Norton E, Goebel S, Desmettre P, Paoletti E (1990) Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J Virol 64:1441–1450PubMedPubMedCentral
100.
van Gennip HG, van Rijn PA, Widjojoatmodjo MN, Moormann RJ (1999) Recovery of infectious classical swine fever virus (CSFV) from full-length genomic cDNA clones by a swine kidney cell line expressing bacteriophage T7 RNA polymerase. J Virol Methods 78:117–128PubMedCrossRef
101.
Vigil A, Martinez O, Chua MA, Garcia-Sastre A (2008) Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther 16:1883–1890PubMedPubMedCentralCrossRef
102.
Villar E, Barroso IM (2006) Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J 23:5–17PubMedCrossRef
103.
Wei CM, Gibson M, Spear PG, Scolnick EM (1981) Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1. J Virol 39:935–944PubMedPubMedCentral
104.
Weissmann C (1978) Reversed genetics. TIBS3:N109-N111
105.
Weissmann C, Weber H, Taniguchi T, Müller W, Meyer F (1978) Site-directed mutagenesis as a tool in genetics: application to RNA and DNA genomes. In: Boyer HW, Nicosia S (eds) Genetic Engineering. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 65–76
106.
Whelan SP, Ball LA, Barr JN, Wertz GT (1995) Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci USA 92:8388–8392PubMedPubMedCentralCrossRef
107.
Whelan SP, Barr JN, Wertz GW (2004) Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283:61–119PubMed
108.
Wilson T, Lenard J (1981) Interaction of wild-type and mutant M protein vesicular stomatitis virus with nucleocapsids in vitro. Biochemistry 20:1349–1354PubMedCrossRef
109.
Wyatt LS, Moss B, Rozenblatt S (1995) Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210:202–205PubMedCrossRef
110.
Xiao S, Nayak B, Samuel A, Paldurai A, Kanabagattebasavarajappa M, Prajitno TY, Bharoto EE, Collins PL, Samal SK (2012) Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain. PLoS One 7:e52751PubMedPubMedCentralCrossRef
111.
112.
Zhang Z, Zhao W, Li D, Yang J, Zsak L, Yu Q (2015) Development of a Newcastle disease virus vector expressing a foreign gene through an internal ribosomal entry site provides direct proof for a sequential transcription mechanism. J Gen Virol 96(8):2028–2035PubMedCrossRef
113.
Zhao W, Zhang Z, Zsak L, Yu Q (2015) P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression. J Gen Virol 96:40–45PubMedCrossRef
114.
Zheng H, Tian H, Jin Y, Wu J, Shang Y, Yin S, Liu X, Xie Q (2009) Development of a hamster kidney cell line expressing stably T7 RNA polymerase using retroviral gene transfer technology for efficient rescue of infectious foot-and-mouth disease virus. J Virol Methods 156:129–137PubMedCrossRef
Metadata
Title
Rescue of recombinant Newcastle disease virus: a short history of how it all started
Authors
Aidin Molouki
Ben Peeters
Publication date
01-07-2017
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2017
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3308-2

Other articles of this Issue 7/2017

Archives of Virology 7/2017 Go to the issue

Original Article

Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice

Original Article

Molecular characterization of neuraminidase genes of influenza A(H3N2) viruses circulating in Southwest India from 2009 to 2013

Original Article

Identification of host factors potentially involved in RTM-mediated resistance during potyvirus long distance movement

Original Article

Genotypic and pathogenic characterization of genotype VII Newcastle disease viruses isolated from commercial farms in Egypt and evaluation of heterologous antibody responses

Virology Division News

Is it time to retire the genus Rymovirus from the family Potyviridae?

Brief Report

Characterization of lettuce big-vein associated virus and Mirafiori lettuce big-vein virus infecting lettuce in Saudi Arabia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits